-
Mashup Score: 0Reinfection for BA.2 After Omicron is Rare - 2 year(s) ago
Although it is possible, a small Danish study showed the majority of these cases were often mild and in unvaccinated individuals.
Source: Contagion LiveCategories: Infectious Disease, Latest HeadlinesTweet
-
Mashup Score: 0FDA Approves New Antibody Drug to Fight Omicron Variant - 2 year(s) ago
FRIDAY, Feb. 11, 2022 (HealthDay News) — The U.S. Food and Drug Administration on Friday gave the nod for a new monoclonal antibody treatment that works against the Omicron variant.The emergency use authorization for bebtelovimab is for the treatment of mild to moderate COVID-19 in adults and pedia…
Source: Consumer Health News | HealthDayCategories: General Medicine News, Latest HeadlinesTweet
-
Mashup Score: 2
The variant is spreading fast. For some, it is causing milder illness. But its distinct qualities have left Americans making a new set of calculations.
Source: www.nytimes.comCategories: Healthcare Professionals, Latest HeadlinesTweet
-
Mashup Score: 1
Research in South Africa raises hopes that similar responses may be present with other vaccines
Source: the GuardianCategories: Healthcare Professionals, Latest HeadlinesTweet
-
Mashup Score: 4
Health officials are stockpiling a monoclonal antibody treatment that has been shown to be effective against omicron in preparation for the variant to become dominant in the United States.David Kessler, chief scientific officer of the White House COVID-19 response team, said treatments of sotrovimab were paused to states after Thanksgiving in order to stockpile for the omicron variant, The…
Source: news.yahoo.comCategories: Healthcare Professionals, Latest HeadlinesTweet
-
Mashup Score: 0
The emergence of this new variant of concern has brought a new vocabulary into daily news reports. We asked experts to help define the terms you’re being bombarded with.
Source: NPR.orgCategories: Healthcare Professionals, Latest HeadlinesTweet
-
Mashup Score: 0Unsung Heroes of the Pandemic: Dogs - 2 year(s) ago
THURSDAY, Dec. 16, 2021 (HealthDay News) — Coping with the isolation, fear and sadness of the pandemic may have been a little easier if you had a trusting and loving dog by your side.But you don’t need to tell that to Francois Martin, a researcher who studies the bonds between animals and humans. H…
Source: Consumer Health News | HealthDayCategories: General Medicine News, Latest HeadlinesTweet
-
Mashup Score: 6
Misinformation about COVID-19, including vaccines, treatments and the government’s role, has been fueling vaccine hesitancy. In this episode, IDSA President Dr. Daniel McQuillen, FIDSA, IDSA President-Elect Dr. Carlos del Rio, FIDSA and John Bridgeland, co-founder and CEO of the COVID Collaborative, discuss what is being done to combat misinformation, how to address myths with vaccine hesitant…
Source: www.idsociety.orgCategories: Infectious Disease, Latest HeadlinesTweet
-
Mashup Score: 12
Wednesday, nearly two weeks after news of Omicron ignited global panic on Nov. 25, Pfizer announced its vaccine works against the variant but provided few details.
Source: New York PostCategories: Future of Medicine, Latest HeadlinesTweet
-
Mashup Score: 0New studies indicate mRNA vaccines provide limited protection against Omicron, but boosters and new shots may be crucial - 2 year(s) ago
The first substantial evidence for how mRNA vaccines will hold up against the new Omicron variant was released Tuesday night from scientists in South Africa. The study, conducted by mixing sera from vaccinated individuals with live Omicron virus, showed that the variant could largely — but not entirely — dodge
Source: Endpoints NewsCategories: Healthcare Professionals, Latest HeadlinesTweet
Although it is possible, a small Danish study showed the majority of these cases were often mild and in unvaccinated individuals. #BA2 #OmicronVarient https://t.co/SZDJ6RVKWD